H-Index
34
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Get your full text copy in PDF

Post-Transplant Diabetes Mellitus (PTDM) in Heart Recipients

Miroslaw Garlicki

Ann Transplant 2005; 10(3): 51-53

ID: 496213


Diabetes mellitus is a metabolic disorder that is prevalent in the general population, with more than one in five people over 50 years of age presenting with the condition [Van Hooff 2004].In general, (post-transplant) diabetes develops as a result of low or absent insulin output, increased insulin resistance, or a combination of the two. Transplant recipients generally take a combination of immunosuppressive drugs. Not only the calcineurin inhibitors cyclosporine and tacrolimus, but also corticosteroids have been associated with disturbances in glucose metabolic control [Van Dujinhoven 2003]. PTDM shares many similarities with type 2 diabetes and it may be reversible [Davidson et al. 2003]. The incidence of PTDM after heart transplantation is generally higher when compared to other organ transplantations [ISHLT 2004]....

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree